DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Kamm MA, Lichtenstein GR, Sandborn WJ et al.
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.
Gut 2008;
57: 893-902
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.